Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
Bioequivalence of Drugs: Drugs with Multiple Indications01:09

Bioequivalence of Drugs: Drugs with Multiple Indications

The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each indication due to...
Bioequivalence: Overview01:16

Bioequivalence: Overview

Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
Equivalence: In Vitro and In Vivo Bioequivalence01:17

Equivalence: In Vitro and In Vivo Bioequivalence

Bioequivalence studies are crucial in evaluating whether new drugs can match an approved one regarding pharmacological effects and clinical performance. These studies test if drugs, despite different dosage forms, share identical plasma concentration-time profiles. Three types of equivalence are central to these studies: chemical, pharmaceutical, and therapeutic. Chemical equivalence indicates that two or more drug products contain identical active ingredients in equal amounts. Pharmaceutical...
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
Bioequivalence Data: Statistical Interpretation01:16

Bioequivalence Data: Statistical Interpretation

The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Healthcare utilization and productivity losses associated with CIDP: results from an international survey.

Frontiers in neurology·2026
Same author

Cost-effectiveness of Pilates compared with home-based exercises for people with chronic non-specific low back pain: a trial-based economic evaluation.

BMC musculoskeletal disorders·2026
Same author

The Association Between Relocations and Health Outcomes in Nursing Home Residents: A Retrospective Cohort Study.

Journal of the American Medical Directors Association·2026
Same author

Oxygen saturation thresholds in children with acute respiratory distress (OxyKids): a multicentre, open, parallel-group, randomised clinical trial.

The Lancet. Respiratory medicine·2026
Same author

What affects unplanned hospital admissions in older adults according to primary healthcare professionals? A focus group study.

The European journal of general practice·2026
Same author

Cost-effectiveness of percutaneous nephrostomy vs JJ stent in obstructive urolithiasis: economic evaluation alongside the STent Or NEphrostomy (STONE) randomised controlled trial.

BJU international·2026

Related Experiment Video

Updated: Jul 6, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Practical guidelines for economic evaluations alongside equivalence trials.

Judith E Bosmans1, Martine C de Bruijne, Hein P J van Hout

  • 1Health Technology Assessment Unit, Institute for Research in Extramural Medicine, VU University Medical Center, Amsterdam, The Netherlands. judith.bosmans@falw.vu.nl

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|April 3, 2008
PubMed
Summary

This study introduces methods for analyzing economic equivalence and noninferiority trials, crucial for comparing new treatments against existing ones. Cost-effectiveness planes aid in interpreting these economic trial results.

Related Experiment Videos

Last Updated: Jul 6, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Area of Science:

  • Health Economics
  • Clinical Trial Design
  • Biostatistics

Background:

  • Established treatments exist for many diseases.
  • New treatments may be evaluated for equivalence or noninferiority to existing ones.
  • Economic evaluations are vital for assessing cost-effectiveness alongside clinical trials.

Purpose of the Study:

  • To propose methods for analyzing economic equivalence and noninferiority studies.
  • To align economic evaluation methods with clinical equivalence/noninferiority trial methodologies.
  • To demonstrate the utility of cost-effectiveness planes in economic trial interpretation.

Main Methods:

  • Adaptation of statistical methods used in clinical equivalence and noninferiority trials for economic evaluations.
  • Application of cost-effectiveness planes for result interpretation.
  • Illustrative examples using data from an economic noninferiority trial.

Main Results:

  • Proposed methods facilitate the analysis of economic equivalence and noninferiority.
  • Cost-effectiveness planes provide a valuable tool for interpreting economic trial outcomes.
  • The study demonstrates practical application of these methods.

Conclusions:

  • Standardized methods for economic equivalence and noninferiority trials enhance study design and analysis.
  • Cost-effectiveness planes are effective for visualizing and interpreting economic trial results.
  • This approach supports informed decision-making in healthcare economics.